PortfoliosLab logoPortfoliosLab logo
HRTS vs. SPAQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HRTS vs. SPAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Horizon Kinetics SPAC Active ETF (SPAQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HRTS achieves a -5.70% return, which is significantly lower than SPAQ's 2.81% return.


HRTS

1D
0.51%
1M
-0.90%
YTD
-5.70%
6M
-5.48%
1Y
20.97%
3Y*
5Y*
10Y*

SPAQ

1D
0.00%
1M
1.51%
YTD
2.81%
6M
1.64%
1Y
4.98%
3Y*
5.87%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HRTS vs. SPAQ - Yearly Performance Comparison


2026 (YTD)202520242023
HRTS
Tema Obesity & Cardiometabolic ETF
-5.70%23.93%-4.30%14.97%
SPAQ
Horizon Kinetics SPAC Active ETF
2.81%7.35%4.33%0.50%

Correlation

The correlation between HRTS and SPAQ is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.02

Correlation (All Time)
Calculated using the full available price history since Nov 22, 2023

0.04

HRTS vs. SPAQ - Sectors Allocation Comparison


Sectors
HRTS
SPAQ

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

91.6%

Industrials

-

0.1%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

HRTS
100.0%
SPAQ

-

Basic Materials

HRTS

-

SPAQ

-

Communication Services

HRTS

-

SPAQ

-

Consumer Cyclical

HRTS

-

SPAQ

-

Consumer Defensive

HRTS

-

SPAQ

-

Energy

HRTS

-

SPAQ

-

Financial Services

HRTS

-

SPAQ
91.6%

Industrials

HRTS

-

SPAQ
0.1%

Real Estate

HRTS

-

SPAQ

-

Technology

HRTS

-

SPAQ

-

Utilities

HRTS

-

SPAQ

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HRTS vs. SPAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS
HRTS Risk / Return Rank: 3636
Overall Rank
HRTS Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
HRTS Sortino Ratio Rank: 3838
Sortino Ratio Rank
HRTS Omega Ratio Rank: 3333
Omega Ratio Rank
HRTS Calmar Ratio Rank: 3939
Calmar Ratio Rank
HRTS Martin Ratio Rank: 3232
Martin Ratio Rank

SPAQ
SPAQ Risk / Return Rank: 2020
Overall Rank
SPAQ Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
SPAQ Sortino Ratio Rank: 1717
Sortino Ratio Rank
SPAQ Omega Ratio Rank: 2020
Omega Ratio Rank
SPAQ Calmar Ratio Rank: 2121
Calmar Ratio Rank
SPAQ Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. SPAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Horizon Kinetics SPAC Active ETF (SPAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HRTSSPAQDifference
Sharpe ratioReturn per unit of total volatility

+0.75

Sortino ratioReturn per unit of downside risk

+1.15

Omega ratioGain probability vs. loss probability

1.23

1.13

+0.10

Calmar ratioReturn relative to maximum drawdown

1.91

0.94

+0.97

Martin ratioReturn relative to average drawdown

4.83

3.39

+1.44

HRTS vs. SPAQ - Sharpe Ratio Comparison

The current HRTS Sharpe Ratio is 1.31, which is higher than the SPAQ Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of HRTS and SPAQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HRTSSPAQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

0.57

+0.75

Sharpe Ratio (All Time)

Calculated using the full available price history

0.55

0.86

-0.31

Drawdowns

HRTS vs. SPAQ - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, which is greater than SPAQ's maximum drawdown of -5.30%. Use the drawdown chart below to compare losses from any high point for HRTS and SPAQ.


Loading charts...

Drawdown Indicators


HRTSSPAQDifference

Max Drawdown

Largest peak-to-trough decline

-25.81%

-5.30%

-20.51%

Max Drawdown (1Y)

Largest decline over 1 year

-11.01%

-5.30%

-5.71%

Max Drawdown (3Y)

Largest decline over 3 years

-5.30%

Current Drawdown

Current decline from peak

-9.14%

-0.01%

-9.13%

Average Drawdown

Average peak-to-trough decline

-9.02%

-0.54%

-8.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.36%

1.47%

+2.89%

Volatility

HRTS vs. SPAQ - Volatility Comparison

Tema Obesity & Cardiometabolic ETF (HRTS) has a higher volatility of 4.44% compared to Horizon Kinetics SPAC Active ETF (SPAQ) at 1.95%. This indicates that HRTS's price experiences larger fluctuations and is considered to be riskier than SPAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HRTSSPAQDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.44%

1.95%

+2.49%

Volatility (6M)

Calculated over the trailing 6-month period

11.26%

5.01%

+6.25%

Volatility (1Y)

Calculated over the trailing 1-year period

16.03%

8.80%

+7.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.07%

7.00%

+12.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.07%

7.00%

+12.07%

HRTS vs. SPAQ - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is lower than SPAQ's 0.85% expense ratio.


Dividends

HRTS vs. SPAQ - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.42%, less than SPAQ's 16.23% yield.


PositionTTM202520242023
HRTS
Tema Obesity & Cardiometabolic ETF
1.42%1.34%1.63%0.00%
SPAQ
Horizon Kinetics SPAC Active ETF
16.23%16.69%3.00%2.60%

Frequently Asked Questions


HRTS and SPAQ have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HRTS has higher volatility (4.44%) compared to SPAQ (1.95%). In terms of maximum drawdown, HRTS dropped -25.81% vs SPAQ's -5.30%.

On 1-year performance, HRTS leads with 20.97% vs 4.98% for SPAQ. On fees, HRTS is cheaper at 0.75% per year. On volatility, SPAQ has been the lower-risk option at 1.95%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, HRTS has performed better with a 20.97% return vs 4.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

HRTS is cheaper with a 0.75% expense ratio, compared with 0.85% for SPAQ.

SPAQ has the higher dividend yield at 16.23%, compared with 1.42% for HRTS.

They also come from different issuers: Tema and Horizon. Their fees differ too: 0.75% for HRTS and 0.85% for SPAQ.

HRTS currently has the higher Sharpe Ratio (1.31 vs 0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HRTS and SPAQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer